RESUMEN
The aim of the study was to evaluate the efficiency and safety of ropivacaine, in comparison with bupivacaine, in axillary brachial plexus block. 24 patients, undergoing upper limb surgery, was divided into 2 homogeneous groups and the local anaesthetics was administered: A (ropivacaine 0.75%, 25 ml; total dose 187.5 mg) and B (bupivacaine 0.5%, 25 ml; total dose 125 mg). The axillary plexus block was executed with the help of an electrostimulator. The results show that using ropivacaine the onset-time is lower and the duration of sensory and motor block is higher than using bupivacaine. In conclusion we can affirm that ropivacaine is a new step in local anaesthetic field.
Asunto(s)
Amidas/administración & dosificación , Anestésicos Locales/administración & dosificación , Plexo Braquial , Bloqueo Nervioso/métodos , Adulto , Axila , Bupivacaína/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , RopivacaínaRESUMEN
The aim of our study was to compare the efficiency of ropivacaine and bupivacaine, in epidural administration, in postoperative analgesia. 20 patients, undergone knee surgery, in epidural anaesthesia (bupivacaine 0.5%-2 mg/Kg-1 administered in level L3L4), was divided into 2 groups (10 each one) and the local anaesthetics in study was administered by epidural catheter with an elastomeric pump: A (ropivacaine 0.15%) and B (bupivacaine 0.15%). The results demonstrate that ropivacaine is better than bupivacaine to keep a check on analgesia in postoperative pain.
Asunto(s)
Amidas/uso terapéutico , Analgesia Epidural , Anestésicos Locales/uso terapéutico , Bupivacaína/uso terapéutico , Ortopedia , Dolor Postoperatorio/tratamiento farmacológico , Adulto , Femenino , Humanos , Inestabilidad de la Articulación/cirugía , Rodilla/cirugía , Masculino , RopivacaínaRESUMEN
The aim of our study was to evaluate the efficiency and safety of mivacurium, comparing two dose-induction in patients undergone a minor orthopaedic surgery. 30 patients were divided into two groups and mivacurium were administered at the dose of 0.15 mg Kg-1 and 0.20 mg Kg-1 respectively. The results confirmed its efficiency in short surgery. Mioresolution was excellent only in the second group (0.20 mg Kg-1) despite an histamine-related blood pressure reduction.